Company:  ENZO BIOCHEM INC (ENZ)
Form Type:  10-K/A
Filing Date:  12/26/1996 
CIK:  0000316253 
Address:  60 EXECUTIVE BLVD 
City, State, Zip:  FARMINGDALE, New York 11735 
Telephone:  (516) 755-5500 
Fiscal Year:  07/31 
Last Trade
Last Trade: 
$2.53  
Change: 
0.00 (0.00%)  
Trade Time: 
Aug 05  
Market Cap: 
$123.26M
Trade ENZ now with 

© 2022  
Description of Business
Enzo Biochem, Inc. (the "Company" "we", "our" or "Enzo") is an integrated diagnostics, clinical lab, and life sciences company focused on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable our customers to meet their clinical needs. Through a connection with the market, we provide advanced biotechnology solutions to the global community as affordable and flexible quality products and services. We develop, manufacture and sell our proprietary technology solutions and platforms to clinical laboratories, specialty clinics, researchers and physicians globally. Enzo's structure and business strategy represent the culmination of years of extensive planning and work. The Company has the unique ability to offer low cost, high performance products and services for diagnostic testing, which ideally positions us to capitalize on the reimbursement pressures facing diagnostic labs.
Register and access this filing in:     
  FORM 10-K/A
    PART I
      Item 1. Business
      Item 2. Properties
      Item 3. Legal Proceedings
      Item 4. Submission of Matters to a Vote of Security Holders
    PART II
      Item 5. Market for Registrant's Common Equity and Related
      Item 6.
      Item 7. Management's Discussion and Analysis of Financial ...
        Liquidity and Capital Resources
        Results of Operations
      Item 8. Financial Statements and Supplementary Data
      Item 9. Changes in and Disagreements with Accountants on
    PART III
      Item 10. Directors and Executive Officers of the Registrant
        NAME AND TITLE
      Item 11. Executive Compensation
      Item 12. Security Ownership of Certain Beneficial Owners ...
      Item 13. Certain Relationships and Related Transactions
    PART IV
      Item 14. Exhibits, Financial Statement Schedules, and Reports
        Report of Independent Auditors
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
    VALUATION AND QUALIFYING ACCOUNTS
  EXHIBIT 10.(Y)
  EXHIBIT 10.(Z)
  EXHIBIT 10.(AA)
  EXHIBIT 10.(BB)
  EXHIBIT 10.(CC)
  EXHIBIT 10.(DD)
  EXHIBIT 21
  EXHIBIT 23
    CONSENT OF INDEPENDENT AUDITORS